TTFields with Temozolomide Recommended by NCCN for Newly Diagnosed GBM

The combination of TTFields and temozolomide has been added by the NCCN to its guidelines for Category 1 treatment for patients with newly diagnosed glioblastoma, following maximal safe resection and completion of radiation therapy.


0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply